High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC
Clinical trial NCT02960607 · UNKNOWN
Trial details
- NCT number
- NCT02960607
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2018-01-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.